SECURE Webinar 19: Enhancing the Quality and Safety of Medicine in Southeast Asia

COVID-19 posed a major challenge to the global health agenda, with pharmaceutical manufacturers shifting their production and distribution processes to rapidly respond to escalating demands for vaccines and medical products. The pandemic also revitalized the importance of sound pharmacovigilance (PV) systems and national regulatory authorities (NRA) to ensure the safety, quality, and efficacy of vaccines and drugs.

Nilgun Aydogan

Keywords

Nilgun Aydogan has been working at Gavi, the Vaccine Alliance, since 2007. She is currently the Senior Country Manager. Prior to this role, she worked on Gavi Civil Society Engagement and managed the EURO and PAHO, Gavi Transitioning Countries.

Before working in Gavi, Nilgun worked with reputable agencies such as UNICEF, IPPF, the World Bank focusing on maternal and early childhood health and care. Over the years she worked and traveled extensively on projects covering North Africa, Middle East, and Central Asia.

Landscape Assessment and Policy Recommendations: Scaling Nucleic Acid-based Biopharmaceutical Technologies in Asia and the Pacific

This presentation gives an overview of the landscape assessment and policy recommendations for scaling nucleic acid-based biopharmaceutical technologies in Asia and Pacific region, with a focus on market assessment, technology overview, and capacity building policy briefs for Bangladesh.

Varun Srivastava

Varun Srivastava is a Manager at Accenture Development Partnerships' Global Health team, based in Bengaluru, India. With over eight years of experience in the development sector, Varun has deep expertise in public health, including immunization, public health supply chains, surveillance, and health systems strengthening.

Ragini Ahluwalia

Keywords

Ragini is the Asia-Pacific Global Health Lead for Accenture Development Partnerships, the social impact and international development arm of Accenture Strategy, and is based in New Delhi, India. She has over 12 years of experience and has participated in and led over 35 projects focused on the domains of life sciences, global health, access and equity, and sustainable development. She specializes in the areas of growth strategy, landscape and opportunity assessment, market sizing, financing evaluation, supply chain assessment, policy reviews, stakeholder engagement, and project management.

Aman Singh

Keywords

Amandeep “Aman” Singh is a Technical Officer with the World Health Organization (WHO) in Vanuatu. Before WHO, Aman worked as a Vaccine Financing Specialist (Consultant) with the Asian Development Bank (ADB) in Vietnam and with Gavi as a Technical Advisor on COVID-19 and Pandemic Preparedness in the Policy Design team of the Office of the COVAX Facility. He has also consulted for the UK Foreign, Commonwealth & Development Office (FCDO) Center for Disaster Protection, advising on the global architecture of pandemic policies and financing.

Jinho Shin

Keywords

Dr. Shin is a Medical Officer of Regulatory Systems Strengthening Essential Medicines and Health Technologies, Division of Health Systems and Services in WHO Regional Office for the Western Pacific. He has served WHO since 2003 for 20 years in developing global written and measurement standards for vaccines and biologicals, strengthening regulatory systems, and improving health equity and international public health protection by supporting Member States.